Effect of a change in reactor power on response of murine solid tumors in vivo, referring to impact on quiescent tumor cell population
- 8 January 2019
- journal article
- research article
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 95 (5) , 635-645
Abstract
Purpose: To examine the effect of a change in reactor power on the response of solid tumors, referring to impact on quiescent (Q) tumor cell population. Materials and Methods: Tumor-bearing mice received 5-bromo-2-deoxyuridine (BrdU) to label all proliferating (P) tumor cells, and were treated with boronophenylalanine-10B (BPA) or sodium mercaptododecaborate-10B (BSH). After reactor neutron beam irradiation at a power of 1 or 5 MW with an identical beam spectrum, cells from tumors were isolated and incubated with a cytokinesis blocker. The responses of BrdU-unlabeled Q and total (= P + Q) tumor cells were assessed based on the frequencies of micronucleation using immunofluorescence staining for BrdU. Results: After neutron irradiation with or without 10B-carrier, radio-sensitivity was reduced by decreasing reactor power in both cells, especially in Q cells and after irradiation with BPA. The values of relative and compound biological effectiveness were larger at a power of 5 MW and in Q cells than at a power of 1 MW and in total cells, respectively. The sensitivity difference between total and Q cells was widened when combined with 10B-carrier, especially with BPA, and through decreasing reactor power. Conclusion: 5 MW is more advantageous than 1 MW for boron neutron capture therapy.Keywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 22 references indexed in Scilit:
- Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancerRadiation Oncology, 2012
- Intra-tumour heterogeneity: a looking glass for cancer?Nature Reviews Cancer, 2012
- Effects of employing a10B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapyBritish Journal of Radiology, 2012
- Combination of the vascular targeting agent ZD6126 with boron neutron capture therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Tumor microenvironmental physiology and its implications for radiation oncologySeminars in Radiation Oncology, 2004
- Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: Its relation to quiescent cell population and tumor cure in neutron capture therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Neutron capture therapy of the 9l rat gliosarcoma using the P-boronophenylalanine-fructose complexInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Response of the central nervous system to boron neutron capture irradiation: evaluation using rat spinal cord modelRadiotherapy and Oncology, 1994
- Dose prescription in boron neutron capture therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Microanalysis system of ppm-order 10B concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometryNuclear Instruments and Methods in Physics Research, 1983